Tillat is a pharmaceutical company that manufactures and commercializes high demand, halal-compliant medications to an array of countries worldwide. Currently, Tillat has a pipeline of 16 halal medications (8 small molecule and 8 biotherapeutic) at various stages of development. The company expects a majority of these medications to be available to consumers, globally, in the second half of 2024.
Company Details
- Employees
- 3
- Address
- San Diego, California, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Manufacturing of Halal Medicine.
- HQ
- San Diego, California
Tillat Pharmaceuticals Questions
Tillat Pharmaceuticals's website is http://www.tillatpharmaceuticals.com
Tillat Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/tillat
Tillat Pharmaceuticals has
3 employees.
View email and phone details for 3
employees at Tillat Pharmaceuticals.
Tillat Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Tillat Pharmaceuticals's top competitors are
Hospital Municipal Albert Schweitzer,
Aeterna Therapeutics,
Cassyni Biopharma,
Replicate Bioscience, Inc.,
Pinaud Investments,
Antharis Therapeutics, Inc.,
Episkin Sa,
Galileo Biotech,
The Fundingsland Group,
Leste Group.
Tillat Pharmaceuticals's categories are Pharmaceutical Manufacturing
